Research ArticleEpidemiology/Health Services Research
Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
Alexandra Fouts, Laura Pyle, Liping Yu, Dongmei Miao, Aaron Michels, Jeffrey Krischer, Jay Sosenko, Peter Gottlieb, Andrea K. Steck, the Type 1 Diabetes TrialNet Study Group
DOI: 10.2337/dc16-0302 Published 1 October 2016
Alexandra Fouts
1Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO
Laura Pyle
2Department of Pediatrics, University of Colorado Denver, Aurora, CO
3Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO
Liping Yu
1Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO
Dongmei Miao
1Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO
Aaron Michels
1Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO
Jeffrey Krischer
4Pediatrics Epidemiology Center, University of South Florida, Tampa, FL
Jay Sosenko
5University of Miami School of Medicine, Miami, FL
Peter Gottlieb
1Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO
Andrea K. Steck
1Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO